Physician profile
Kyle Lester
NPI 1225441660
$3,832.47
in general payments reported to CMS, 2019-2025
32 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2021: $413 · 2022: $463 · 2023: $653 · 2024: $1,589 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,938 · Travel and Lodging: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.71 |
| Travel and Lodging | $659.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,066.71 | 2021-2024 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $277.14 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Janssen Biotech, INC. | $268.85 | 2023-2025 | Erleada |
| Pfizer INC. | $266.31 | 2021-2025 | |
| Myovant Sciences INC. | $224.17 | 2021-2022 | |
| Teleflex LLC | $209.32 | 2022-2024 | Urolift |
| Bioprotect Medical, INC. | $157.32 | 2024 | Bioprotect Balloon Implant System |
| Laborie Medical Technologies Corp. | $137.33 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $124.13 | 2019 | |
| Progenics Pharmaceuticals, INC. | $124.08 | 2022-2023 | Pylarify |
| Blue Earth Diagnostics | $114.69 | 2019 | |
| Antares Pharma, INC. | $114.50 | 2024-2025 | Xyosted |
| Sumitomo Pharma America, INC. | $89.86 | 2023 | Gemtesa, Orgovyx |
| Tempus Ai, INC | $88.90 | 2024 | Xt Cdx |
| Astellas Pharma US INC | $81.53 | 2022-2023 | Myrbetriq |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $51.61 | 2025 | |
| Endo Pharmaceuticals INC. | $50.03 | 2021-2023 | Xiaflex |
| Hollister Incorporated | $48.21 | 2023-2024 | Infyna Chic, Vapro Pocket |
| Urogen Pharma, INC. | $43.56 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $34.79 | 2024 | |
| Novartis Pharmaceuticals Corporation | $34.60 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $32.88 | 2021-2022 | |
| Bluewind Medical | $31.73 | 2024 | Revi |
| Halozyme INC | $27.71 | 2023 | |
| Lumenis, INC | $21.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.41 | 2025 | |
| Verity Pharmaceuticals INC. | $18.96 | 2025 | Tlando |
| Amgen INC. | $18.96 | 2021 | |
| Medtronic, INC. | $14.27 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.27 | 2024 | Adstiladrin |
| Acerus Pharmaceuticals Corporation | $12.00 | 2022 | |
| Clarus Therapeutics INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.